These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35965551)

  • 1. UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.
    Chen H; Zhang J; Zhou H; Zhu Y; Liang Y; Zhu P; Zhang Q
    Front Oncol; 2022; 12():934145. PubMed ID: 35965551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
    Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
    BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
    Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
    J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.
    Zhu Y; Wang L; Nong Y; Liang Y; Huang Z; Zhu P; Zhang Q
    Cancer Manag Res; 2021; 13():8865-8878. PubMed ID: 34858060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
    Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomics Identified Lyso-Phosphatidylcholine and Phosphatidylethanolamine as Potential Biomarkers for Diagnosis of Laryngeal Cancer.
    Yu B; Wang J
    Front Oncol; 2021; 11():646779. PubMed ID: 34262857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
    Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
    J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
    Cheng F; Wen Z; Feng X; Wang X; Chen Y
    Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
    Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
    Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
    Liu T; Tan Z; Yu J; Peng F; Guo J; Meng W; Chen Y; Rao T; Liu Z; Peng J
    Expert Rev Proteomics; 2020 Mar; 17(3):233-242. PubMed ID: 32306783
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer.
    Liu X; Xu X; Pan B; He B; Chen X; Zeng K; Xu M; Pan Y; Sun H; Xu T; Hu X; Wang S
    J Cancer; 2019; 10(1):43-50. PubMed ID: 30662524
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.
    Wang H; Zhang B; Li X; Zhou D; Li Y; Jia S; Qi S; Xu A; Zhao X; Wang J; Bai Z; Cao B; Li N; Dai M; Chen H; Huang J
    Front Oncol; 2020; 10():1081. PubMed ID: 32793472
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.